OBJECTIVES: The purpose of this study was to compare bone marrow aspirate concentrate (BMAC) with cancellous allograft to iliac crest bone graft (ICBG) in the treatment of long bone nonunions. DESIGN: Retrospective cohort study. SETTING: A single level I trauma center. PATIENTS: 26 patients with long bone diaphyseal or metaphyseal nonunions with defects >2 mm and treated with open repair and BMAC, compared to 25 patients with long bone diaphyseal or metaphyseal nonunions with defects >2 mm and treated with open repair and ICBG. INTERVENTION: Open repair of long bone nonunion using either autologous ICBG or BMAC with cancellous allograft. MAIN OUTCOME MEASURE: Nonunion healing, radiographically measured by the modified Radiographic Union Score for Tibia (mRUST) score. Secondary outcomes included risk factors associated with failed repair. RESULTS: The union rates for the BMAC and ICBG cohorts were 75% and 78%, respectively (P = .8). Infection was the only risk factor of statistical significance for failure. CONCLUSION: In this study, we found no significant difference in union rate for long bone nonunions treated with ICBG or BMAC with allograft. BMAC and allograft led to 75% successful healing in this series. Given the heterogeneity of the control group and loss to follow-up, further prospective investigation should be conducted to more rigorously compare BMAC to ICBG for nonunion treatment. LEVEL OF EVIDENCE: III, retrospective cohort.
OBJECTIVES: The purpose of this study was to compare bone marrow aspirate concentrate (BMAC) with cancellous allograft to iliac crest bone graft (ICBG) in the treatment of long bone nonunions. DESIGN: Retrospective cohort study. SETTING: A single level I trauma center. PATIENTS: 26 patients with long bone diaphyseal or metaphyseal nonunions with defects >2 mm and treated with open repair and BMAC, compared to 25 patients with long bone diaphyseal or metaphyseal nonunions with defects >2 mm and treated with open repair and ICBG. INTERVENTION: Open repair of long bone nonunion using either autologous ICBG or BMAC with cancellous allograft. MAIN OUTCOME MEASURE: Nonunion healing, radiographically measured by the modified Radiographic Union Score for Tibia (mRUST) score. Secondary outcomes included risk factors associated with failed repair. RESULTS: The union rates for the BMAC and ICBG cohorts were 75% and 78%, respectively (P = .8). Infection was the only risk factor of statistical significance for failure. CONCLUSION: In this study, we found no significant difference in union rate for long bone nonunions treated with ICBG or BMAC with allograft. BMAC and allograft led to 75% successful healing in this series. Given the heterogeneity of the control group and loss to follow-up, further prospective investigation should be conducted to more rigorously compare BMAC to ICBG for nonunion treatment. LEVEL OF EVIDENCE: III, retrospective cohort.
Authors: Alan L Jones; Robert W Bucholz; Michael J Bosse; Sohail K Mirza; Thomas R Lyon; Lawrence X Webb; Andrew N Pollak; Jane Davis Golden; Alexandre Valentin-Opran Journal: J Bone Joint Surg Am Date: 2006-07 Impact factor: 5.284
Authors: Diyar Delawi; Wilco Jacobs; Job L C van Susante; Ludovic Rillardon; Domenico Prestamburgo; Nicola Specchia; Emmanuel Gay; Nico Verschoor; Carlos Garcia-Fernandez; Enrique Guerado; Henriette Quarles van Ufford; Moyo C Kruyt; Wouter J A Dhert; F Cumhur Oner Journal: J Bone Joint Surg Am Date: 2016-03-16 Impact factor: 5.284
Authors: William D Lack; Madhav A Karunakar; Marc R Angerame; Rachel B Seymour; Stephen Sims; James F Kellam; Michael J Bosse Journal: J Orthop Trauma Date: 2015-01 Impact factor: 2.512
Authors: Michael A Flierl; Wade R Smith; Cyril Mauffrey; Kaan Irgit; Allison E Williams; Erin Ross; Gabrielle Peacher; David J Hak; Philip F Stahel Journal: J Orthop Surg Res Date: 2013-09-09 Impact factor: 2.359